SDS

1207906 - ECOBOND Lead Defender
Revision Date 10-Mar-2016
_____________________________________________________________________________________________
_____________________________________________________________________________________________
Page 8 / 12
Symptoms
No information available.
Delayed and immediate effects as well as chronic effects from short and long-term exposure
Sensitization
No information available.
Mutagenic Effects
No information available.
Carcinogenicity
The table below indicates whether each agency has listed any ingredient as a carcinogen.
This product contains titanium dioxide which is classified as a possible carcinogen when
present as respirable dust. This is not relevant for this product since it is a liquid.
Petroleum distillates are known to cause cancer because of the potential for carcinogenic
components present during manufacturing. These carcinogens are removed during
refinement of the distillate. The petroleum distiallate present in this product is highly
refined and should not be considered a carcinogen.
Chemical name
ACGIH
IARC
NTP
OSHA
Titanium dioxide
13463-67-7
Group 2B
X
Talc
14807-96-6
Group 3
Supplier Trade Secret
A2
Group 1
X
Supplier Trade Secret
A2
Group 1
X
Diatomaceous earth
61790-53-2
Group 3
X
Supplier Trade Secret
Group 2B
X
ACGIH (American Conference of Governmental Industrial Hygienists)
A2 - Suspected Human Carcinogen
IARC (International Agency for Research on Cancer)
Group 1 - Carcinogenic to Humans
Group 2B - Possibly Carcinogenic to Humans
Group 3 - Not Classifiable as to Carcinogenicity in Humans
OSHA (Occupational Safety and Health Administration of the US Department of Labor)
X - Present
Reproductive toxicity
No information available.
STOT - single exposure
No information available.
STOT - repeated exposure
No information available.
Chronic Toxicity
No known effect based on information supplied.
Target Organ Effects
Respiratory system. Eyes. Skin. Gastrointestinal tract (GI).
Aspiration Hazard
No information available.
Numerical measures of toxicity Product Information
The following values are calculated based on chapter 3.1 of the GHS document
ATEmix (oral)
10,476.00 mg/kg
ATEmix (dermal)